C2orf69P4

Across TCGA pan-cancer cohorts, C2orf69P4 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated C2orf69P4 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher C2orf69P4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated C2orf69P4 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

UCEC, BLCA, and OV are the cancer types where C2orf69P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	III,IV	0.053	0.588	.005	54	view →
BLCA	OS	Tertile	II,III,IV	1.000	0.413	.042	12	view →
OV	OS	Tertile	II,III,IV	0.629	0.846	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

C2orf69P4–UCEC (OS)

Open the UCEC breakdown →